Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient levothyroxine sodium, ATC H03AA01
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
Conclusion of non-exclusive discount contracts in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicines with the above-mentioned active ingredients within the period from January 1st, 2027 to December 31st, 2028 with the possibility of concluding a contract at any time (open-house model). In the open house procedure, medicines according to the BfArM list according to Section 35 Paragraph 5a SGB V (children's medicines) are excluded.